Thrasos is a therapeutics company, engages in the discovery and development of targeted therapies for the prevention and treatment of
Renal disease... Read more
Thrasos is a therapeutics company, engages in the discovery and development of targeted therapies for the prevention and treatment of
Renal disease... Read more
CEO
Add
News
Feb 29, 2016
BioPortfolio
Thrasos: Thrasos Announces Promising Results for Phase 2 THR184 Dose Ranging Clinical Study for the Prevention of Acute Kidney Injury AKI
Nov 11, 2015
BIOSPACE
Thrasos: Thrasos Strengthens Composition Of Matter Coverage On THR-184 With Japanese Patent Decision
Nov 11, 2015
BUSINESS WIRE
Press Release: Thrasos : Thrasos Strengthens Composition of Matter Coverage on THR-184 with Japanese Patent Decision
Sep 02, 2015
BIOSPACE
Thrasos: Thrasos To Present At The 22nd Annual NewsMakers And Conferences
Sep 02, 2015
BUSINESS WIRE
Press Release: Thrasos : Thrasos to Present at the 22nd Annual BioCentury NewsMakers and 8th Annual BioPharm America Conferences
Jul 09, 2015
BIOSPACE
Thrasos: EXCLUSIVE: Thrasos to Seek Breakthrough Status for Kidney Injury Drug, CEO Says
Jul 07, 2015
BIOSPACE
Thrasos: Thrasos Completes Enrollment Of Phase II THR-184 Clinical Study For Acute Kidney Injury
Jul 07, 2015
BUSINESS WIRE
Press Release: Thrasos : Thrasos Completes Enrollment of Phase 2 THR-184 Clinical Study for Acute Kidney Injury
Apr 01, 2015
PE HUB
Thrasos: Thrasos Innovation raises $21 mln
Apr 01, 2015
VCAONLINE
Thrasos:
Thrasos Secures $21 Million to Complete Phase 2 Study of THR-184 in the Prevention of Acute Kidney Injury and Expand the Company�s Renal Portfolio
Thrasos Therapeutics Inc Competitors
1
2
3
4
5
6
7
8
9
10